Pabrinex shortage and guidance on alternatives
Pabrinex IV will be out of stock from July/ August 2024 until September 2025, due to supply issues relating to manufacturing regulations issued by the EU. Pabrinex IM will be permanently discontinued from December 2024. Pabrinex is only used in the UK, with thiamine IV/ IM being routinely used globally.
It is important to note if a Patient Group Direction (PGD) is being used (often used in community setting), only licensed products can be used in this setting. Therefore IM Pabrinex should be conserved for this purpose.
The following has been published online by the DHSC Specialist Pharmacy Service.
Joanna Henry, Gastroenterology Directorate Pharmacist, Liverpool University Hospitals NHS Trust
Sital Shah, Chair British Hepatology Pharmacy Group , Consultant Pharmacist, King’s College Hospital, London
BSG San Diego Travelling Fellowship Report by Amy Johnson
I am incredibly grateful to the Liver Section for awarding me this travelling fellowship. My time in San Diego was immensely beneficial for my career development, offering both educational and networking opportunities that I will build upon for years to come.
BSG San Diego Travelling Fellowship Report by Wenhao Li
I am writing to thank the BSG for providing financial support in order for me to attend MetALD meeting, AASLD meeting followed by a short stay with Prof Rohit Loomba’s team at UCSD.
HCC - Improving liver cancer surveillance in the UK
This channel presents video extracts from a meeting on "Improving hepatocellular carcinoma surveillance" held in Birmingham UK, April 2024. The meeting was supported by the British Association for Study of Liver (BASL) and the British Society of Gastroenterology (BSG). The aim of the meeting was discuss/showcase existing initiatives and new ideas for improving liver cancer surveillance in the UK.